TP53 and breast cancer: Apart from BRCA1/2, GPVs located in seven other genes - ATM, BARD1, CHEK2, PALB2, RAD51C, RAD51D and TP53 – have shown to be clinically relevant, increasing the risk to develop BC (5–9).